Mark G. Edwards is Managing Director of Bioscience Advisors Inc., a biopharmaceutical consulting firm he founded in 2011. Previously, he was Managing Director and a Principal of Deloitte Recap LLC, a wholly-owned subsidiary of Deloitte Touche Tohmatsu. Until its sale to Deloitte in 2008, Mr. Edwards was the Managing Director and founder of Recombinant Capital, Inc. (Recap), a consulting and database firm based in Walnut Creek, California. Prior to founding Recap in 1988, Mr. Edwards was Manager of Business Development at Chiron Corporation. He is on the board of directors of the California Institute for Biomedical Research (Calibr) and AcelRx Pharmaceuticals and has previously served on the boards of Allos Therapeutics, CombiMatrix and Ontogen. Mr. Edwards received his B.A. and M.B.A. degrees from Stanford University.
What is driving/sustaining the widest and longest-open IPO window, with 350 newly-public companies?…